Select Your Region
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGA Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25
Fulfilled By ChemPoint
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is an advanced controlled drug release agent form Evonik containing 50 mol % D,L-lactide and 50 mol % Glycolide with no added preservatives. LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 has an inherent viscosity range of 0.15─0.25 dL/g in HFIP and a degradation period of 3 months.
Documents
Specifications
Physical state: Solid
Form: Granules
Color: White to light tan
Inherent viscosity (IV) dL/g: 0.15─0.25 (in HFIP)
Degradation time: <3 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS no. 26780-50-7;
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
Manufacturer
Product Line
Product
Industries
Authorized Countries
Canada
United States
Overview
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is a 100% bioresorbable PLGA-based copolymer available as a white to light tan granule solid pellet with an inherent viscosity of 0.15─0.25 dL/g in HFIP. As part of Evonik's LACTEL® polymer line, it offers exceptional controlled release of pharmaceutical ingredients in long-acting injectable formulations for human generic drug formulations and veterinary medicine with high functionality and advanced metabolization in the body. It offers a cost-effective option, available in small volumes and can be optimized to meet progress requirements. LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is non-GMO and contains no added preservatives.
Features & Benefits
- 50:50 ratio of D,L-Lactide and Glycolide
- Acid end group
- No added preservatives
- Non-GMO
- Amorphous
- 3 month degradation period
- Bioabsorbable excipient
- Suitable for use with small molecules, peptides, proteins, and other substances
- Unpurified
- Cost-effective
- Non-GMO
Applications
Human generic drug formulations
Long-acting injectable formulations
Price sensitive applications
veterinary medicine
Related Applications
Pharmaceuticals
Related Functions
Pharmaceuticals
Global Supply Chain
Global Warehouse Network
Strategically located across North America and EMEA for fast, reliable delivery. Every order, every time.
0
North America
0
EMEA
North America
EMEA
ChemPoint Is Here to Help
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States
